Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach: Effects of aging and ulcers

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 278, Issue 5 41-5, 2000, Pages

  Vogiagis, Daphne ^a   Glare, Eric M ^a   Misajon, Aileen ^a   Brown, Wendy ^a   O'Brien, Paul E ^a  

^a MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

Author keywords

Competitive PCR; Gastric ulcer; Gene expression; Splice variant; Ulcer healing

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MESSENGER RNA;

AGING; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; GENE EXPRESSION SYSTEM; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; STOMACH ULCER; ULCER HEALING;

EID: 0034119475     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2000.278.5.g820     Document Type: Article

References (45)

1. Atamas S. Alternative splice variants of cytokines - making a list. Life Sci 61: 1105-1112, 1997.
2. Bak Andersen I, Bonnevie O, Jorgensen T, and Sorensen T. Time trends for peptic ulcer disease in Denmark, 1981-1993. Scand J Gastroenterol 33: 260-266, 1998.
3. Cohn S, Schloemann S, Tessner T, Siebert K, and Stenson W. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest 99: 1367-1379, 1997.
4. Cryer B, Lee E, and Feldman M. Factors influencing gastroduodenal mucosal prostaglandin concentrations in humans: relationship with gastric acid secretion. Ann Intern Med 116: 636-640, 1992.
5. Cryer B, Redfern J, Goldshmiedt M, Lee E, and Fledman M. Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans. Gastroenterology 102: 1118-1123, 1992.
6. De Witt D and Meade E. Serum and glucocorticoid regulation of gene transcription and expression of prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch Biochem Biophys 306: 94-102, 1993.
7. Dinchuk J, Car B, Focht R, Johnston J, Jaffee B, Covington M, Contel N, Eng V, Collins R, Czerniak P, Gorry S, and Trzaskos J. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409, 1995.
8. DuBois R, Radhika A, Reddy B, and Entingh A. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumours. Gastroenterology 110: 1259-1262, 1996.
9. Feng L, Sun W, Xia Y, Tang W, Chanmugam P, Soyoola E, Wilson C, and Hwang D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys 307: 361-368, 1993.
10. Ferraz J-G, Sharkey K, Reuter B, Asfaha S, Tigley A, Brown M, McKnight W, and Wallace J. Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage. Gastroenterology 113: 195-204, 1997.
11. Fletcher B, Kujubu D, Perrin D, and Herschman H. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10 encoded protein is a functional prostaglandin G/H synthase. J Biol Chem 267: 4338-4344, 1992.
12. Glare E, Divjak M, Rolland J, and Walters E. Asthmatic airway biopsy specimens are more likely to express the IL-4 alternative splice variant IL-482. J Allergy Clin Immunol. 104: 978-982, 1999.
13. Iseki I. Immunocytochmical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach. Histochem J 27: 323-328, 1995.
14. Kargman S, Charleson S, Cartwright M, Frank J, Riendeau D, Mancini J, Evans J, and O'Neill G. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tracts. Gastroenterology 111: 445-454, 1996.
15. Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 63: 584-592, 1972.
16. Kishimoto Y, Wada K, Nakamoto K, Kawasaki H, and Hasegawa J. Levels of cyclooxygenase-1 and -2 mRNA expression at various stages of acute gastric injury induced by ischemiareperfusion in rats. Arch Biochem Biophys 352: 153-157, 1998.
17. Kitzler J, Hill E, Hardman R, Reddy N, Philpot R, and Eling T. Analysis and quantitation of splicing variants of the TPA-inducible PGHS-1 mRNA in rat tracheal epithelial cells. Arch Biochem Biophys 316: 856-863, 1995.
18. Komhoff M, Grone H-J, Klein T, Seyberth H, and Nusing R. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol Renal Physiol 272: F460-F468, 1997.
19. Konturek S, Stachura J, Radecki T, Drozdowicz D, and Brzozowski T. Cytoprotective and ulcer healing properties of prostaglandin E2, colloidal bismuth and sucralfate in rats. Digestion 38: 103-113, 1987.
20. Langenbach R, Morham S, Tiano H, Loftin C, Ghanayem B, Chulada P, Mahler J, Lee C, Goulding E, Kluckman K, Kim H, and Smithies O. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83: 483-492, 1995.
21. Lee M. Prevention and treatment of nonsteroidal anti-inflammatory drug-induced gastropathy. South Med J 88: 507-513, 1995.
22. Lee M and Feldman M. Age-related reductions in gastric mucosal prostaglandin levels increase susceptibility to aspirininduced injury in rats. Gastroenterology 107: 1746-1750, 1994.
23. Magnuson V, Young M, Schattenberg D, Mancini M, Chen D, Steffensen B, and Klebe R. The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. JBiol Chem 266:14654-14662, 1991.
24. Masferrer J, Zweifel B, Manning P, Hauser S, Leahy K, Smith W, Isakson P, and Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91: 3228-3232, 1994.
25. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, and Kasuga M. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112: 387-397, 1997.
26. Morita I, Schindler M, Regier M, Otto J, Hori T, DeWitt D, and Smith W. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270: 10902-10908, 1995.
27. O'Neill G and Ford-Hutchinson A. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330: 156-160, 1993.
28. Otto J and Smith W. The orientation of endoperoxide synthases-1 and -2 in the endoplasmic reticulum. J Biol Chem 269: 19868-19875, 1994.
29. Pairet M and Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol 10:1-15, 1996.
30. Penney A, Andrews F, and O'Brien P. Effects of misoprostol on delayed ulcer healing induced by aspirin. Dig Dis Sci 39: 943-939, 1994.
31. Peri K, Hardy P, Li D, Varma D, and Chemtob S. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in newborn. JBiol Chem 270: 24615-24620, 1995.
32. Regier M, De Witt D, Schnider M, and Smith W. Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 3T3 cells. Arch Biochem Biophys 301: 439-444, 1993.
33. Ristimaki A, Honkanen N, Jankala H, Sipponen P, and Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57: 1276-1280, 1997.
34. Schmassmann A, Peskar B, Stettler C, Netzer P, Stroff T, Flogerzi B, and Halter F. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcers models in rats. Br JPharmacol 123: 795-804, 1998.
35. Shaw G and Kamen R. A conserved AU sequence from the 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667, 1986.
36. Soll A, Weinstein W, Kurata J, and McCarthy D. Nonsteroidal antiinflammatory drugs and peptic ulcer disease. Ann Intern Med 114: 307-319, 1991.
37. Takahashi S, Shigeta J-I, Inoue H, Tanabe T, and Okabe S. Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats. Am J Physiol Gastrointest Liver Physiol 275: G1137-G1145, 1998.
38. 2 level in rats. Dig Dis Sci 35: 80-85, 1990.
39. Vane J. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232-234, 1971.
40. Vane J, Mitchell J, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, and Willoughby D. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 91: 2046-2050, 1994.
41. Wheater P, Burkitt H, Stevens A, and Lowe J (eds.). Basic Histopathology. Edinburgh: Churchill Livingstone, 1985, p. 17-35.
42. Whittle B, Higgs G, Eakins K, Moncada S, and Vane J. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 284: 271-273, 1980.
43. Xie W, Chipman J, Robertson D, Erison R, and Simmons D. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88: 2692-2696, 1991.
44. Yamagata K, Andreasson K, Kaufmann W, Barnes C, and Worley P. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11: 371-386, 1993.
45. Zimmermann K, Serbia M, Sehror K, and A Weber-A. Consitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa. Mol Pharmacol 54: 536-540, 1998.